Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAP Advance Auto Parts	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Zaccone Subscribe to MarketBeat All Access for the recommendation accuracy rating	$43.46 -2.0%	$44.00 ➝ $47.00	Neutral ➝ Neutral
AAPL Apple	Target Raised by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$245.55 -0.1%	$215.00	Hold
ACHR Archer Aviation	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Savanthi Syth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.13 -9.9%	$11.00 ➝ $12.00	Outperform ➝ Outperform
AG First Majestic Silver	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Heiko Ihle Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.55 -3.7%	$11.00 ➝ $11.00	Buy ➝ Buy
AGI Alamos Gold	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$32.32 -2.1%	C$44.00 ➝ C$46.00
AIF Altus Group	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$55.00 -1.5%	C$56.00 ➝ C$62.00
AIF Altus Group	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$55.00 -1.5%	C$60.00 ➝ C$57.00
AKAM Akamai Technologies	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Frank Louthan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.73 -21.7%	$115.00 ➝ $110.00	Outperform ➝ Outperform
AKAM Akamai Technologies	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.73 -21.7%	$100.00 ➝ $90.00	Sector Perform ➝ Sector Perform
AKAM Akamai Technologies	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Elias Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.73 -21.7%	$125.00 ➝ $98.00	Buy ➝ Hold
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
AKAM Akamai Technologies	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.73 -21.7%	$112.00 ➝ $100.00	Overweight ➝ Neutral
AKAM Akamai Technologies	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Madeline Brooks Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.73 -21.7%	$125.00 ➝ $100.00	Buy ➝ Neutral
AKAM Akamai Technologies	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aaron Samuels Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.73 -21.7%	$110.00 ➝ $105.00	Positive ➝ Positive
AKAM Akamai Technologies	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.73 -21.7%	$76.00 ➝ $72.00	Underweight ➝ Underweight
AKAM Akamai Technologies	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.73 -21.7%	$115.00 ➝ $107.00	Sector Outperform ➝ Sector Outperform
AKAM Akamai Technologies	Downgraded by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.73 -21.7%	$90.00	Buy ➝ Hold
AKAM Akamai Technologies	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt Dezort Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.73 -21.7%		Hold ➝ Hold
ALIT Alight	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.83 -1.5%	$9.00 ➝ $9.00	Buy ➝ Buy
ALTR Altair Engineering	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Shi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$111.78		Hold ➝ Hold
AMAL Amalgamated Financial	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Fitzgibbon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.56 -7.7%	$42.00 ➝ $38.00	Overweight ➝ Neutral
AMN AMN Healthcare Services	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.50 +6.4%	$47.00 ➝ $40.00	Buy ➝ Buy
ANSS ANSYS	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Blair Abernethy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$334.21 -1.8%	$335.00 ➝ $340.00	Neutral ➝ Neutral
ARDX Ardelyx	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.06 -11.6%	$5.50 ➝ $5.50	Neutral ➝ Neutral
ARDX Ardelyx	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Deschner Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.06 -11.6%	$15.00 ➝ $13.00	Strong-Buy ➝ Strong-Buy
AVTX Avalo Therapeutics	Initiated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.44 +17.9%	$18.00	Outperform
AXTI AXT	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.58 -31.0%	$5.50 ➝ $4.50	Outperform
AXTI AXT	Reiterated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dave Kang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.58 -31.0%	$5.50 ➝ $6.00	Buy ➝ Buy
AXTI AXT	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Charles Shi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.58 -31.0%	$5.00 ➝ $5.00	Buy ➝ Buy
BABA Alibaba Group	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eddie Leung Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.67 +5.7%	$117.00 ➝ $150.00	Buy ➝ Buy
BABA Alibaba Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jiong Shao Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.67 +5.7%	$130.00 ➝ $180.00	Overweight ➝ Overweight
BABA Alibaba Group	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fawne Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.67 +5.7%	$118.00 ➝ $190.00	Buy ➝ Buy
BABA Alibaba Group	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Yao Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.67 +5.7%	$125.00 ➝ $170.00	Overweight ➝ Overweight
BAH Booz Allen Hamilton	Downgraded by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Louie DiPalma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$112.27 -1.2%		Outperform ➝ Market Perform
BAND Bandwidth	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.00 -2.6%		Outperform
BAND Bandwidth	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Macwilliams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.00 -2.6%	$25.00 ➝ $22.00	Overweight ➝ Overweight
BAND Bandwidth	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Koontz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.00 -2.6%		Hold ➝ Hold
BAX Baxter International	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robbie Marcus Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.87 +1.3%	$38.00 ➝ $36.00	Neutral ➝ Neutral
BBIO BridgeBio Pharma	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Lebowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.85 +0.1%	$45.00 ➝ $49.00	Buy ➝ Buy
BBIO BridgeBio Pharma	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Josh Schimmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.85 +0.1%	$95.00 ➝ $95.00	Overweight ➝ Overweight
BBIO BridgeBio Pharma	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Harrison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.85 +0.1%	$49.00 ➝ $52.00	Sector Outperform ➝ Sector Outperform
Grab This Altcoin Before Trump's Crypto Announcement (Ad) Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now
BEEP Mobile Infrastructure	Initiated by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Diana Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.07 -6.1%	$7.00	Buy
BIGC BigCommerce	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.23 -0.2%	$10.00 ➝ $10.00	Buy ➝ Buy
BILI Bilibili	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Shao Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.82 +3.2%	$24.00 ➝ $25.00	Overweight ➝ Overweight
BILI Bilibili	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fawne Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.82 +3.2%	$24.00 ➝ $30.00	Buy ➝ Buy
BJRI BJ's Restaurants	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nick Setyan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.09 +6.6%	$43.00 ➝ $48.00	Outperform ➝ Outperform
BJRI BJ's Restaurants	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.09 +6.6%	$34.00 ➝ $37.00	Underweight ➝ Underweight
BKNG Booking	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ross Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$5,100.00 ➝ $5,600.00	Overweight ➝ Overweight
BKNG Booking	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Naved Khan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$5,700.00 ➝ $6,000.00	Buy ➝ Buy
BKNG Booking	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$4,470.00 ➝ $5,248.00	Equal Weight ➝ Equal Weight
BKNG Booking	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Champion Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$4,900.00 ➝ $5,120.00	Neutral ➝ Neutral
BKNG Booking	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Doug Anmuth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$5,575.00 ➝ $5,750.00	Overweight ➝ Overweight
BKNG Booking	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Kurnos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$5,000.00 ➝ $5,900.00	Buy ➝ Buy
BKNG Booking	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tom White Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$5,005.00 ➝ $5,800.00	Buy ➝ Buy
BKNG Booking	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Mathivanan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$4,900.00 ➝ $5,540.00	Neutral ➝ Neutral
BKNG Booking	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ronald Josey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$5,500.00 ➝ $5,800.00	Buy ➝ Buy
BKNG Booking	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Pitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$5,155.00 ➝ $5,900.00	Outperform ➝ Outperform
BKNG Booking	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brad Erickson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$5,250.00 ➝ $5,900.00	Outperform ➝ Outperform
BKNG Booking	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lloyd Walmsley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4,989.22 -0.6%	$5,560.00 ➝ $5,960.00	Buy ➝ Buy
BLDR Builders FirstSource	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Dahl Subscribe to MarketBeat All Access for the recommendation accuracy rating	$137.14 -5.0%	$167.00 ➝ $162.00	Outperform ➝ Outperform
BLDR Builders FirstSource	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Hughes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$137.14 -5.0%	$220.00 ➝ $180.00	Buy ➝ Buy
BLDR Builders FirstSource	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Perron-Piche Subscribe to MarketBeat All Access for the recommendation accuracy rating	$137.14 -5.0%	$200.00 ➝ $180.00	Buy ➝ Buy
BLDR Builders FirstSource	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reuben Garner Subscribe to MarketBeat All Access for the recommendation accuracy rating	$137.14 -5.0%	$200.00 ➝ $170.00	Buy ➝ Buy
BLDR Builders FirstSource	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Darkatsh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$137.14 -5.0%	$180.00 ➝ $170.00	Outperform ➝ Outperform
BNTC Benitec Biopharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.30 -2.3%	$28.00 ➝ $28.00	Buy ➝ Buy
BTG B2Gold	Upgraded by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Gray Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.82 +0.4%		Hold ➝ Moderate Buy
BTO B2Gold	Upgraded by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Gray Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$4.00 +1.0%	C$4.50 ➝ C$6.25	Market Perform ➝ Buy
BXC BlueLinx	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reuben Garner Subscribe to MarketBeat All Access for the recommendation accuracy rating	$82.40 -8.7%	$135.00 ➝ $120.00	Buy ➝ Buy
BXC BlueLinx	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Stevenson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$82.40 -8.7%	$135.00 ➝ $120.00	Buy ➝ Buy
CACI CACI International	Downgraded by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Louie DiPalma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$326.55 -4.4%		Outperform ➝ Market Perform
CARG CarGurus	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Pierce Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.15 -17.1%	$45.00 ➝ $45.00	Buy ➝ Buy
CARG CarGurus	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rajat Gupta Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.15 -17.1%	$40.00 ➝ $42.00	Overweight ➝ Overweight
CAVA CAVA Group	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jon Tower Subscribe to MarketBeat All Access for the recommendation accuracy rating	$108.05 -8.9%	$163.00 ➝ $140.00	Neutral ➝ Neutral
CBT Cabot	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$84.56 -1.1%	$105.00 ➝ $85.00	Underweight ➝ Underweight
CCAP Crescent Capital BDC	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Finian O'Shea Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.42 -3.3%	$19.00 ➝ $18.00	Equal Weight ➝ Equal Weight
CCL.B CCL Industries	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$72.93 -1.4%	C$85.00 ➝ C$86.00
CCO Cameco	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$61.87 -6.1%	C$91.00 ➝ C$90.00	Buy
CCRD CoreCard	Reiterated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Goetsch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.54 -6.4%	$16.00 ➝ $21.00	Neutral ➝ Neutral
CDE Coeur Mining	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joe Reagor Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.45 -10.7%	$8.50 ➝ $8.25	Buy ➝ Buy
CDE Coeur Mining	Upgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Macarthur Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.45 -10.7%	$8.75 ➝ $8.25	Market Perform ➝ Outperform
CELH Celsius	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sean McGowan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.62 +27.8%	$38.00 ➝ $38.00	Buy ➝ Buy
CELH Celsius	Reiterated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Van Sinderen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.62 +27.8%	$44.00 ➝ $49.00	Buy ➝ Buy
CERS Cerus	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ross Osborn Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.65 -5.2%	$4.00 ➝ $4.00	Overweight ➝ Overweight
CGNX Cognex	Downgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.80 -1.8%	$33.00	Buy ➝ Hold
CHD Church & Dwight	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the recommendation accuracy rating	$105.40 +0.9%	$107.00 ➝ $106.00	Underweight ➝ Underweight
CHDN Churchill Downs	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Stantial Subscribe to MarketBeat All Access for the recommendation accuracy rating	$116.92 -1.8%	$164.00 ➝ $161.00	Buy ➝ Buy
CHDN Churchill Downs	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Politzer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$116.92 -1.8%	$165.00 ➝ $158.00	Overweight ➝ Overweight
CHH Choice Hotels International	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Powell Subscribe to MarketBeat All Access for the recommendation accuracy rating	$150.53 -1.2%	$129.00 ➝ $132.00	Underweight ➝ Underweight
CHR Chorus Aviation	Upgraded by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. James Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$19.56 +1.6%	C$25.00 ➝ C$27.00	Hold ➝ Buy
CHR Chorus Aviation	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$19.56 +1.6%	C$26.00 ➝ C$28.00
CLS Celestica	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$119.41 -4.5%	$166.00	Overweight
Critical ‘Buy Now’ Alert on My Favorite Stock! (Ad) My absolute favorite stock just hit a critical "buy now" trigger price. Click here for the ticker >>>
COIN Coinbase Global	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Colonnese Subscribe to MarketBeat All Access for the recommendation accuracy rating	$235.38 -8.3%	$350.00 ➝ $350.00	Buy ➝ Buy
CP Canadian Pacific Kansas City	Target Lowered by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$110.12 -0.4%	C$123.00 ➝ C$122.00
CQP Cheniere Energy Partners	Downgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Benjamin Nolan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$62.31 -1.3%	$50.00 ➝ $51.00	Hold ➝ Sell
CRM Salesforce	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$309.54 -2.8%	$425.00 ➝ $375.00	Outperform ➝ Outperform
CRWD CrowdStrike	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$406.61 -6.8%	$372.00 ➝ $506.00	Overweight ➝ Overweight
CSGS CSG Systems International	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.01 -0.4%	$75.00	Buy
CTRE CareTrust REIT	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Carroll Subscribe to MarketBeat All Access for the recommendation accuracy rating	$24.90 -2.8%	$37.00 ➝ $32.00	Outperform ➝ Outperform
CUBE CubeSmart	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Luebchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.82 -0.4%	$50.00 ➝ $44.00	Equal Weight ➝ Equal Weight
CVE Cenovus Energy	Downgraded by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$20.75 -4.2%	C$28.00 ➝ C$25.00	Outperform ➝ Sector Perform
CVE Cenovus Energy	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Greg Pardy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.61 -4.5%	$26.00 ➝ $25.00	Outperform ➝ Outperform
CVE Cenovus Energy	Downgraded by	National Bank Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Wood Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.61 -4.5%		Outperform ➝ Sector Perform
CVNA Carvana	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael McGovern Subscribe to MarketBeat All Access for the recommendation accuracy rating	$223.14 -9.9%	$252.00 ➝ $270.00	Buy ➝ Buy
CVNA Carvana	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Josey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$223.14 -9.9%	$277.00 ➝ $320.00	Buy ➝ Buy
CWAN Clearwater Analytics	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.35 +4.7%	$34.00 ➝ $36.00	Overweight ➝ Overweight
CWK Cushman & Wakefield	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Blouin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.68 -4.6%	$14.50 ➝ $13.00	Sell ➝ Sell
DAN Dana	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tom Narayan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.71 -3.7%	$13.00 ➝ $16.00	Sector Perform ➝ Sector Perform
DAVA Endava	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Friedman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.06 -7.9%	$55.00 ➝ $50.00	Positive ➝ Positive
DAVA Endava	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.06 -7.9%	$43.00 ➝ $38.00	Buy ➝ Buy
DELL Dell Technologies	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the recommendation accuracy rating	$117.66 -1.9%	$156.00 ➝ $145.00	Buy ➝ Buy
DNB Dun & Bradstreet	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	George Tong Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.45 +0.1%	$12.80 ➝ $11.00	Neutral ➝ Neutral
DNB Dun & Bradstreet	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.45 +0.1%	$17.00 ➝ $14.00	Buy ➝ Buy
DRS Leonardo DRS	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Seth Seifman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.85 -7.5%	$32.00 ➝ $33.00	Neutral ➝ Neutral
DUK Duke Energy	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$115.58 +2.1%	$129.00 ➝ $132.00	Buy ➝ Buy
DVAX Dynavax Technologies	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.33		Outperform
DVAX Dynavax Technologies	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Edward White Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.33	$31.00 ➝ $31.00	Buy ➝ Buy
EADSY Airbus	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.72 -3.5%		Buy ➝ Hold
ELAN Elanco Animal Health	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.02 -1.0%	$18.00 ➝ $16.00	Buy ➝ Buy
ELF e.l.f. Beauty	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Kanada Subscribe to MarketBeat All Access for the recommendation accuracy rating	$74.76 +5.1%	$142.00 ➝ $124.00	Buy ➝ Buy
EPRX Eupraxia Pharmaceuticals	Initiated by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.65 +2.8%	$12.00	Buy
ESAB ESAB	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tami Zakaria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.07 0.0%	$135.00 ➝ $133.00	Overweight ➝ Overweight
ESAB ESAB	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nathan Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.07 0.0%	$131.00 ➝ $125.00	Hold ➝ Hold
EVH Evolent Health	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.44 -2.5%	$17.00 ➝ $16.00	Overweight ➝ Overweight
EVH Evolent Health	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Macdonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.44 -2.5%	$15.00 ➝ $15.00	Buy ➝ Buy
EXPI eXp World	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tom White Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.26 -9.5%	$13.50 ➝ $13.50	Neutral ➝ Neutral
EXR Extra Space Storage	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Luebchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$155.85 -0.1%	$170.00 ➝ $165.00	Equal Weight ➝ Equal Weight
FCN FTI Consulting	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$164.51 +0.9%	$275.00 ➝ $225.00	Buy ➝ Buy
FCN FTI Consulting	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$164.51 +0.9%	$194.00 ➝ $173.00	Neutral ➝ Neutral
FIVN Five9	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Blakey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.09 +1.0%	$46.00 ➝ $57.00	Overweight ➝ Overweight
FIVN Five9	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.09 +1.0%		Outperform
FIVN Five9	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.09 +1.0%	$46.00 ➝ $53.00	Overweight ➝ Overweight
FIVN Five9	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.09 +1.0%	$52.00 ➝ $52.00	Buy ➝ Buy
FIVN Five9	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Macwilliams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.09 +1.0%	$55.00 ➝ $60.00	Overweight ➝ Overweight
FIVN Five9	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.09 +1.0%	$50.00 ➝ $58.00	Buy ➝ Buy
FND Floor & Decor	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.25 +1.5%	$115.00 ➝ $115.00	Outperform ➝ Outperform
FND Floor & Decor	Upgraded by	Gordon Haskett Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Grom Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.25 +1.5%	$120.00	Hold ➝ Buy
FR First Industrial Realty Trust	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Caitlin Burrows Subscribe to MarketBeat All Access for the recommendation accuracy rating	$55.69 -0.1%	$52.00 ➝ $59.00	Sell ➝ Neutral
FRPT Freshpet	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Marc Torrente Subscribe to MarketBeat All Access for the recommendation accuracy rating	$100.26 -5.8%	$170.00 ➝ $142.00	Overweight ➝ Overweight
FRPT Freshpet	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Lavery Subscribe to MarketBeat All Access for the recommendation accuracy rating	$100.26 -5.8%	$180.00 ➝ $160.00	Overweight ➝ Overweight
FRPT Freshpet	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Astrachan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$100.26 -5.8%	$165.00 ➝ $155.00	Buy ➝ Buy
FSUN Firstsun Capital Bancorp	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Clark Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.33 -0.4%	$51.00	Overweight
Market down? Do this now. (Ad) During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself. Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit. Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too. Download your Free 2025 Gold Guide Now
FUFU BitFuFu	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Dede Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.35 +10.8%	$7.00 ➝ $7.00	Buy ➝ Buy
GD General Dynamics	Downgraded by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Louie DiPalma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$243.02 -1.3%		Outperform ➝ Market Perform
GDS GDS	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Frank Louthan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$44.76 -7.7%	$25.00 ➝ $53.00	Outperform ➝ Outperform
GDYN Grid Dynamics	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.37 +4.3%	$25.00 ➝ $30.00	Buy ➝ Buy
GH Guardant Health	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.87 -9.6%	$39.00 ➝ $59.00	Outperform ➝ Outperform
GH Guardant Health	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rachel Vatnsdal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.87 -9.6%	$50.00 ➝ $55.00	Overweight ➝ Overweight
GH Guardant Health	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Arias Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.87 -9.6%	$45.00 ➝ $53.00	Buy ➝ Buy
GH Guardant Health	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Sykes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.87 -9.6%	$49.00 ➝ $56.00	Buy ➝ Buy
GKOS Glaukos	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$126.03 -19.9%	$153.00 ➝ $160.00	Overweight ➝ Overweight
GKOS Glaukos	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Saxon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$126.03 -19.9%	$149.00 ➝ $176.00	Buy ➝ Buy
GLBE Global-E Online	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Madhukar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$45.07 -3.3%	$68.00 ➝ $64.00	Buy ➝ Buy
GLOB Globant	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$152.02 -27.7%	$265.00 ➝ $220.00	Buy ➝ Buy
GLOB Globant	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Arvind Ramnani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$152.02 -27.7%	$237.00 ➝ $230.00	Overweight ➝ Overweight
GLOB Globant	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tien-Tsin Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$152.02 -27.7%	$248.00 ➝ $242.00	Overweight ➝ Overweight
GMED Globus Medical	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vik Chopra Subscribe to MarketBeat All Access for the recommendation accuracy rating	$80.43 -4.4%	$95.00 ➝ $93.00	Overweight ➝ Overweight
GMED Globus Medical	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mathew Blackman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$80.43 -4.4%	$92.00 ➝ $94.00	Buy ➝ Buy
GMED Globus Medical	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Saxon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$80.43 -4.4%		Hold ➝ Hold
GMGI Golden Matrix Group	Initiated by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jack Vander Aarde Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.15 +0.5%	$4.00	Buy
GRAB Grab	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ranjan Sharma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.90 +2.5%	$5.60	Neutral ➝ Overweight
GRNT Granite Ridge Resources	Downgraded by	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Johnston Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.13 -4.4%		Overweight ➝ Equal Weight
H Hydro One	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$44.56 +1.3%	C$43.00 ➝ C$46.00
HAS Hasbro	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Megan Alexander Subscribe to MarketBeat All Access for the recommendation accuracy rating	$67.56 -2.2%	$88.00 ➝ $84.00	Overweight ➝ Overweight
HAS Hasbro	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Handler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$67.56 -2.2%	$68.00 ➝ $82.00	Buy ➝ Buy
HBCP Home Bancorp	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Scouten Subscribe to MarketBeat All Access for the recommendation accuracy rating	$47.75 -2.0%	$60.00	Overweight
HL Hecla Mining	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.23 -7.2%	$7.00 ➝ $6.50	Buy
HLIT Harmonic	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.52 -1.2%		Hold
ICLR ICON Public	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$201.39 -0.2%	$275.00 ➝ $240.00	Overweight ➝ Overweight
IIPR Innovative Industrial Properties	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Fortune Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.94 +0.1%	$140.00 ➝ $130.00	Buy ➝ Buy
IMAX IMAX	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Karnovsky Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.03 -3.4%	$25.00 ➝ $27.00	Neutral ➝ Neutral
IMO Imperial Oil	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$99.26 -3.9%	C$94.00 ➝ C$97.00	Hold
IMUX Immunic	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.26 +6.6%	$10.00 ➝ $10.00	Buy ➝ Buy
INDI indie Semiconductor	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Vinh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.41 -12.8%	$8.00 ➝ $7.00	Overweight ➝ Overweight
INDI indie Semiconductor	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Cody Acree Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.41 -12.8%	$9.00 ➝ $8.00	Buy ➝ Buy
INE Innergex Renewable Energy	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$8.95 +5.0%	C$8.00 ➝ C$9.00	Hold
INGM Ingram Micro	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Sabadra Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.29 -1.6%	$26.00 ➝ $28.00	Outperform ➝ Outperform
INOD Innodata	Target Raised by	BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Hamed Khorsand Subscribe to MarketBeat All Access for the recommendation accuracy rating	$61.89 +13.4%	$45.00 ➝ $74.00	Buy ➝ Buy
INOD Innodata	Target Raised by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Allen Klee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$61.89 +13.4%	$54.00 ➝ $75.00	Buy ➝ Buy
INSM Insmed	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nicole Germino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$81.06 -3.0%	$105.00 ➝ $108.00	Buy ➝ Buy
INSM Insmed	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Willey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$81.06 -3.0%	$97.00 ➝ $96.00	Buy ➝ Buy
INSM Insmed	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$81.06 -3.0%	$90.00 ➝ $90.00	Buy ➝ Buy
IRTC iRhythm Technologies	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Treybeck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$119.58 +6.1%	$86.00 ➝ $104.00	Equal Weight ➝ Equal Weight
IRTC iRhythm Technologies	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Saxon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$119.58 +6.1%	$125.00 ➝ $138.00	Buy ➝ Buy
IRTC iRhythm Technologies	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$119.58 +6.1%	$111.00 ➝ $145.00	Buy ➝ Buy
ISTR Investar	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Scouten Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.56 -2.2%	$21.00	Neutral
ITCI Intra-Cellular Therapies	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Fadia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$128.60 +0.0%		Hold ➝ Hold
ITGR Integer	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robert Wasserman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$129.96 -3.9%	$140.00 ➝ $150.00	Buy ➝ Buy
ITGR Integer	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.96 -3.9%		Outperform ➝ Market Perform
IVA Inventiva	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.84 +3.6%	$10.00	Buy
IVN Ivanhoe Mines	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$14.97 -11.3%	C$21.00 ➝ C$19.00
JACK Jack in the Box	Downgraded by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Setyan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.46 -2.1%	$50.00 ➝ $40.00	Outperform ➝ Neutral
70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad) Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here <<
JMIA Jumia Technologies	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Erickson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.76 -2.3%	$5.00 ➝ $4.75	Sector Perform ➝ Sector Perform
KAR OPENLANE	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gary Prestopino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.96 +0.2%	$25.00 ➝ $25.00	Outperform ➝ Outperform
KRUS Kura Sushi USA	Upgraded by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$69.85 -5.7%	$103.00 ➝ $103.00	Hold ➝ Buy
L Loblaw Companies	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$175.89 +0.7%	C$202.00 ➝ C$195.00
L Loblaw Companies	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$175.89 +0.7%	C$206.00 ➝ C$208.00
L Loblaw Companies	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Carden Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$175.89 +0.7%	C$225.00 ➝ C$210.00
LAMR Lamar Advertising	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Karnovsky Subscribe to MarketBeat All Access for the recommendation accuracy rating	$121.91 -0.3%	$129.00 ➝ $126.00	Neutral ➝ Neutral
LAW CS Disco	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.24 +4.8%	$8.00 ➝ $8.00	Buy ➝ Buy
LDOS Leidos	Downgraded by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Louie DiPalma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$126.66 -2.6%		Outperform ➝ Market Perform
LITE Lumentum	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.35 -3.9%		Buy
LKQ LKQ	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Samik Chatterjee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.49 -3.0%	$48.00 ➝ $49.00	Overweight ➝ Overweight
LNF Leon's Furniture	Target Set by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$25.76 -0.3%	C$32.00	Outperform
LNG Cheniere Energy	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Benjamin Nolan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$220.90 -2.7%	$237.00 ➝ $255.00	Buy ➝ Buy
LOPE Grand Canyon Education	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Silber Subscribe to MarketBeat All Access for the recommendation accuracy rating	$181.70 -3.0%	$181.00 ➝ $202.00	Outperform ➝ Outperform
LUMN Lumen Technologies	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Luebchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.68 -0.3%	$5.00	Underweight ➝ Equal Weight
LYV Live Nation Entertainment	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Karnovsky Subscribe to MarketBeat All Access for the recommendation accuracy rating	$149.37 -1.9%	$150.00 ➝ $170.00	Overweight ➝ Overweight
LYV Live Nation Entertainment	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Handler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$149.37 -1.9%	$152.00 ➝ $174.00	Buy ➝ Buy
MD Pediatrix Medical Group	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Macdonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.57 -9.6%	$15.00 ➝ $18.00	Hold ➝ Hold
MD Pediatrix Medical Group	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.57 -9.6%	$16.50 ➝ $18.50	Neutral ➝ Neutral
MDLZ Mondelez International	Downgraded by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.70 +4.1%		Buy ➝ Hold
MELI MercadoLibre	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Trevor Young Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2,260.00 +7.1%	$2,200.00 ➝ $2,500.00	Overweight ➝ Overweight
MELI MercadoLibre	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robert Ford Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2,260.00 +7.1%	$2,500.00 ➝ $3,000.00	Buy ➝ Buy
MELI MercadoLibre	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Friedman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2,260.00 +7.1%	$2,350.00 ➝ $2,760.00	Positive ➝ Positive
MELI MercadoLibre	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Mathivanan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2,260.00 +7.1%	$2,150.00 ➝ $3,000.00	Overweight ➝ Overweight
MFC Manulife Financial	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$43.16 -4.4%	C$47.00 ➝ C$48.00
MFC Manulife Financial	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Darko Mihelic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$30.36 -4.6%	$49.00 ➝ $51.00	Outperform ➝ Outperform
MNDY monday.com	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$300.65 -2.4%	$340.00 ➝ $450.00	Buy ➝ Buy
MNOV MediciNova	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.83 +3.1%	$9.00 ➝ $9.00	Buy ➝ Buy
NA National Bank of Canada	Downgraded by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Persaud Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$124.43 +0.8%		Moderate Buy ➝ Hold
NBIS Nebius Group	Target Raised by	BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Khorsand Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.83 -13.9%	$51.00 ➝ $60.00	Buy ➝ Buy
NBIX Neurocrine Biosciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.69 +3.9%	$185.00 ➝ $185.00	Buy ➝ Buy
NICE NICE	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tavy Rosner Subscribe to MarketBeat All Access for the recommendation accuracy rating	$155.39 +1.2%	$286.00 ➝ $226.00	Overweight ➝ Overweight
NICE NICE	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the recommendation accuracy rating	$155.39 +1.2%	$225.00 ➝ $200.00	Buy ➝ Buy
NICE NICE	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$155.39 +1.2%	$260.00 ➝ $200.00	Outperform ➝ Outperform
NICE NICE	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Blakey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$155.39 +1.2%	$176.00 ➝ $161.00	Neutral ➝ Neutral
NOG Northern Oil and Gas	Downgraded by	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Johnston Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.01 -6.7%		Overweight ➝ Equal Weight
NOK Nokia Oyj	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sandeep Deshpande Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.94 -1.1%	$6.35 ➝ $6.30	Overweight ➝ Overweight
NSA National Storage Affiliates Trust	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Luebchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.68 -0.3%	$40.00 ➝ $38.00	Underweight ➝ Underweight
NTES NetEase	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fawne Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.22 +1.8%	$105.00 ➝ $115.00	Buy ➝ Buy
NTIOF National Bank of Canada	Downgraded by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Persaud Subscribe to MarketBeat All Access for the recommendation accuracy rating	$87.37 +0.4%		Moderate Buy ➝ Hold
NTR Nutrien	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Garchitorena Subscribe to MarketBeat All Access for the recommendation accuracy rating	$52.68 -0.9%	$53.00 ➝ $56.00	Equal Weight ➝ Equal Weight
NVEE NV5 Global	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.75 +1.8%	$27.00 ➝ $28.00	Buy ➝ Buy
NVEE NV5 Global	Target Lowered by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tate Sullivan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.75 +1.8%	$29.00 ➝ $24.00	Buy ➝ Buy
OEC Orion	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.11 -0.3%	$21.00 ➝ $18.00	Overweight ➝ Overweight
OLED Universal Display	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Ricchiuti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$157.30 +6.8%	$215.00 ➝ $170.00	Buy ➝ Buy
OLED Universal Display	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mehdi Hosseini Subscribe to MarketBeat All Access for the recommendation accuracy rating	$157.30 +6.8%	$165.00 ➝ $160.00	Neutral ➝ Neutral
OLED Universal Display	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Searle Subscribe to MarketBeat All Access for the recommendation accuracy rating	$157.30 +6.8%	$207.00 ➝ $213.00	Buy ➝ Buy
ORIC ORIC Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.68 +2.8%	$21.00 ➝ $21.00	Buy ➝ Buy
OSIS OSI Systems	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Seth Seifman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.27 -5.6%	$225.00	Neutral
OWLT Owlet	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.22 +5.1%	$8.50	Buy
OXY Occidental Petroleum	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$50.42 -3.2%		Equal Weight ➝ Equal Weight
PET Wag! Group	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tom White Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.30 -1.5%	$6.50 ➝ $6.00	Buy ➝ Buy
PEY Peyto Exploration & Development	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$16.57 +0.6%	C$19.00 ➝ C$20.00	Buy
PIF Polaris Renewable Energy	Upgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Magder Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$11.85 -1.4%		Strong-Buy
PLL Piedmont Lithium	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joe Reagor Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.15 -4.1%	$13.00 ➝ $8.25	Neutral ➝ Neutral
PODD Insulet	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jayson Bedford Subscribe to MarketBeat All Access for the recommendation accuracy rating	$282.80 -1.9%	$294.00 ➝ $328.00	Outperform ➝ Outperform
PODD Insulet	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mathew Blackman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$282.80 -1.9%	$245.00 ➝ $293.00	Hold ➝ Hold
PODD Insulet	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt O'Brien Subscribe to MarketBeat All Access for the recommendation accuracy rating	$282.80 -1.9%	$285.00 ➝ $310.00	Overweight ➝ Overweight
PODD Insulet	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lawrence Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$282.80 -1.9%	$305.00 ➝ $322.00	Overweight ➝ Overweight
PODD Insulet	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kyle Rose Subscribe to MarketBeat All Access for the recommendation accuracy rating	$282.80 -1.9%	$304.00 ➝ $324.00	Buy ➝ Buy
PODD Insulet	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$282.80 -1.9%	$310.00 ➝ $355.00	Buy ➝ Buy
PRMB Primo Brands	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.00 +4.3%	$40.00 ➝ $48.00	Buy
PRMB Primo Brands	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the recommendation accuracy rating	$34.00 +4.3%	$38.00 ➝ $41.00	Overweight ➝ Overweight
PRTA Prothena	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Li Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.56 +2.0%	$40.00 ➝ $40.00	Buy ➝ Buy
PRTA Prothena	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.56 +2.0%	$48.00 ➝ $48.00	Buy ➝ Buy
PRTA Prothena	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Abrahams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.56 +2.0%	$24.00 ➝ $20.00	Sector Perform ➝ Sector Perform
PRTA Prothena	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Schmidt Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.56 +2.0%		Overweight ➝ Overweight
PSA Public Storage	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Luebchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$304.30 +0.1%	$365.00 ➝ $330.00	Overweight ➝ Overweight
PSN Parsons	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Khanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.45 -4.0%	$105.00	Buy ➝ Hold
PSTG Pure Storage	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the recommendation accuracy rating	$65.14 -3.9%	$75.00 ➝ $80.00	Buy ➝ Buy
PTGX Protagonist Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Zhong Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.75 +0.7%	$58.00	Outperform
PUMP ProPetro	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Gengaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.12 +0.9%	$11.00 ➝ $12.00	Buy ➝ Buy
PWR Quanta Services	Initiated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Philip Shen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$269.75 -4.1%	$350.00	Buy
QUAD Quad/Graphics	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Steinke Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.01 -8.2%	$10.00 ➝ $10.00	Outperform ➝ Outperform
RDDT Reddit	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Champion Subscribe to MarketBeat All Access for the recommendation accuracy rating	$166.27 -5.2%	$210.00 ➝ $220.00	Overweight ➝ Overweight
RGEN Repligen	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rachel Vatnsdal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$158.99 -2.3%	$190.00 ➝ $200.00	Overweight ➝ Overweight
RGEN Repligen	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	$158.99 -2.3%	$180.00 ➝ $180.00	Buy ➝ Buy
RGEN Repligen	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Mikson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$158.99 -2.3%	$165.00 ➝ $170.00	Hold ➝ Hold
RGEN Repligen	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Conor McNamara Subscribe to MarketBeat All Access for the recommendation accuracy rating	$158.99 -2.3%	$203.00 ➝ $205.00	Outperform ➝ Outperform
RGTI Rigetti Computing	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.75 -6.3%	$2.50 ➝ $14.00	Buy ➝ Buy
RIVN Rivian Automotive	Downgraded by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Sheppard Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.97 -4.7%	$13.00 ➝ $15.00	Overweight ➝ Neutral
RIVN Rivian Automotive	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.97 -4.7%	$11.00 ➝ $13.00	Neutral ➝ Neutral
RIVN Rivian Automotive	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Pierce Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.97 -4.7%	$14.00 ➝ $17.00	Buy ➝ Buy
RIVN Rivian Automotive	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Colin Langan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.97 -4.7%	$11.00 ➝ $14.00	Equal Weight ➝ Equal Weight
RL Ralph Lauren	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$277.92 -3.0%	$285.00 ➝ $342.00	Overweight ➝ Overweight
RNG RingCentral	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.90 -6.1%	$45.00 ➝ $40.00	Buy ➝ Buy
RNG RingCentral	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Koontz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.90 -6.1%	$42.00 ➝ $36.00	Buy ➝ Buy
RNG RingCentral	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Macwilliams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.90 -6.1%	$37.00 ➝ $31.00	Equal Weight ➝ Equal Weight
RNG RingCentral	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.90 -6.1%	$38.00 ➝ $31.00	Neutral ➝ Neutral
RNG RingCentral	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.90 -6.1%	$45.00 ➝ $40.00	Outperform ➝ Outperform
RNG RingCentral	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Taylor McGinnis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.90 -6.1%	$40.00 ➝ $38.00	Neutral ➝ Neutral
RNW ReNew Energy Global	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Justin Clare Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.11 -3.8%	$8.00 ➝ $7.50	Buy ➝ Buy
RYAN Ryan Specialty	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Meyer Shields Subscribe to MarketBeat All Access for the recommendation accuracy rating	$65.55 -4.4%	$77.00 ➝ $76.00	Outperform ➝ Outperform
RYAN Ryan Specialty	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Elyse Greenspan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$65.55 -4.4%	$64.00 ➝ $69.00	Equal Weight ➝ Equal Weight
RYAN Ryan Specialty	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Heleniak Subscribe to MarketBeat All Access for the recommendation accuracy rating	$65.55 -4.4%	$73.00 ➝ $72.00	Sector Perform ➝ Sector Perform
SABR Sabre	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Knoblauch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.52 +8.9%	$4.00 ➝ $4.00	Neutral ➝ Neutral
SEDG SolarEdge Technologies	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Philip Shen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.62 -3.1%	$17.00 ➝ $20.00	Neutral ➝ Neutral
SEDG SolarEdge Technologies	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.62 -3.1%	$9.00 ➝ $12.00	Underperform ➝ Underperform
SFM Sprouts Farmers Market	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bill Kirk Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.32 -15.6%	$105.00 ➝ $146.00	Neutral ➝ Neutral
SFM Sprouts Farmers Market	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Edward Kelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.32 -15.6%	$140.00 ➝ $170.00	Equal Weight ➝ Equal Weight
SFM Sprouts Farmers Market	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kelly Bania Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.32 -15.6%	$140.00 ➝ $180.00	Market Perform ➝ Market Perform
SFM Sprouts Farmers Market	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.32 -15.6%	$174.00 ➝ $200.00	Buy ➝ Buy
SHAK Shake Shack	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jake Bartlett Subscribe to MarketBeat All Access for the recommendation accuracy rating	$108.96 -11.9%	$143.00 ➝ $154.00	Buy ➝ Buy
SHAK Shake Shack	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nick Setyan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$108.96 -11.9%	$115.00 ➝ $125.00	Neutral ➝ Neutral
SHAK Shake Shack	Reiterated by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Charles Subscribe to MarketBeat All Access for the recommendation accuracy rating	$108.96 -11.9%	$140.00 ➝ $140.00	Buy ➝ Buy
SNOW Snowflake	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the recommendation accuracy rating	$177.79 -3.9%	$200.00 ➝ $220.00	Buy ➝ Buy
SNOW Snowflake	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Turrin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$177.79 -3.9%	$200.00 ➝ $210.00	Overweight ➝ Overweight
SNX TD SYNNEX	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ashish Sabadra Subscribe to MarketBeat All Access for the recommendation accuracy rating	$141.61 -1.2%	$140.00 ➝ $165.00	Outperform ➝ Outperform
SON Sonoco Products	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Roxland Subscribe to MarketBeat All Access for the recommendation accuracy rating	$46.88 +1.4%	$68.00 ➝ $60.00	Buy ➝ Buy
SPRY ARS Pharmaceuticals	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Hanbury-Brown Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.24 -4.6%		Outperform
STGW Stagwell	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Cahall Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.30 +2.4%	$8.00 ➝ $9.00	Equal Weight ➝ Overweight
SVI StorageVault Canada	Upgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Sturges Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$4.00 +7.2%		Hold ➝ Moderate Buy
SVV Savers Value Village	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.10 -19.2%	$14.00 ➝ $13.00	Buy ➝ Buy
SVV Savers Value Village	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.10 -19.2%	$10.00 ➝ $9.00	Neutral ➝ Neutral
SWTX SpringWorks Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the recommendation accuracy rating	$58.29 -2.7%	$74.00 ➝ $74.00	Buy ➝ Buy
TALK Talkspace	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.01 -8.5%		Hold ➝ Hold
TELO Telomir Pharmaceuticals	Initiated by	Rodman & Renshaw Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.91 -6.5%	$15.00	Buy
TFII TFI International	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.69 -6.7%	$163.00 ➝ $107.00	Buy ➝ Neutral
TFII TFI International	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Bruce Chan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.69 -6.7%	$147.00 ➝ $120.00	Hold ➝ Hold
TFII TFI International	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Walter Spracklin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.69 -6.7%	$156.00 ➝ $127.00	Outperform ➝ Outperform
TFII TFI International	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jordan Alliger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.69 -6.7%	$176.00 ➝ $150.00	Buy ➝ Buy
TFII TFI International	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Chiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.69 -6.7%	$160.00 ➝ $141.00	Outperformer ➝ Outperformer
TLN Talen Energy	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$218.80 -7.5%		Outperform
TPIC TPI Composites	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Philip Shen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.46 -0.3%	$2.75 ➝ $1.50	Neutral ➝ Neutral
TRGP Targa Resources	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$200.89 -1.9%	$204.00 ➝ $220.00	Overweight ➝ Overweight
TRIP Tripadvisor	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Doug Anmuth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.11 -8.4%	$14.00 ➝ $15.00	Underweight ➝ Underweight
TRIP Tripadvisor	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Mathivanan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.11 -8.4%	$14.00 ➝ $13.00	Underweight ➝ Underweight
TRNO Terreno Realty	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Caitlin Burrows Subscribe to MarketBeat All Access for the recommendation accuracy rating	$67.08 +0.4%	$65.00 ➝ $77.00	Neutral ➝ Buy
TRUE TrueCar	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rajat Gupta Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.50 -6.4%		Overweight ➝ Neutral
TS Tenaris	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Gengaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.72 -2.3%	$40.00 ➝ $43.00	Buy ➝ Buy
TVTX Travere Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Agrawal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.98 -6.8%		Overweight ➝ Overweight
TXG Torex Gold Resources	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$33.03 -6.0%	C$36.00 ➝ C$42.00
TXRH Texas Roadhouse	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jake Bartlett Subscribe to MarketBeat All Access for the recommendation accuracy rating	$169.13 -1.4%	$209.00 ➝ $205.00	Buy ➝ Buy
TXRH Texas Roadhouse	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Logan Reich Subscribe to MarketBeat All Access for the recommendation accuracy rating	$169.13 -1.4%	$200.00 ➝ $180.00	Sector Perform ➝ Sector Perform
TXRH Texas Roadhouse	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jon Tower Subscribe to MarketBeat All Access for the recommendation accuracy rating	$169.13 -1.4%	$212.00 ➝ $213.00	Buy ➝ Buy
TXRH Texas Roadhouse	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jim Salera Subscribe to MarketBeat All Access for the recommendation accuracy rating	$169.13 -1.4%	$186.00 ➝ $180.00	Equal Weight ➝ Equal Weight
TXRH Texas Roadhouse	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris O'Cull Subscribe to MarketBeat All Access for the recommendation accuracy rating	$169.13 -1.4%	$185.00 ➝ $172.00	Hold ➝ Hold
TXRH Texas Roadhouse	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nick Setyan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$169.13 -1.4%	$220.00 ➝ $200.00	Outperform ➝ Outperform
TXRH Texas Roadhouse	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$169.13 -1.4%	$194.00 ➝ $178.00	Equal Weight ➝ Equal Weight
U Unity Software	Upgraded by	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Khallouf Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.31 +1.1%		Strong-Buy
U Unity Software	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Brondolo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.31 +1.1%	$20.00 ➝ $27.00	Equal Weight ➝ Equal Weight
U Unity Software	Upgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.31 +1.1%	$34.00	Hold ➝ Buy
U Unity Software	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bernie McTernan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.31 +1.1%	$26.00 ➝ $33.00	Buy ➝ Buy
U Unity Software	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ross Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.31 +1.1%	$18.00 ➝ $26.00	Equal Weight ➝ Equal Weight
U Unity Software	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Uerkwitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.31 +1.1%	$23.00 ➝ $28.00	Hold ➝ Hold
U Unity Software	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Cost Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.31 +1.1%	$26.00 ➝ $32.00	Overweight ➝ Overweight
UBER Uber Technologies	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.89 -2.9%		Buy ➝ Buy
UEIC Universal Electronics	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Frankel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.15 -11.6%	$15.00 ➝ $15.00	Buy ➝ Buy
UL Unilever	Upgraded by	DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.14 +1.1%		Hold ➝ Buy
ULS UL Solutions	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	George Tong Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.05 -1.8%	$51.00 ➝ $57.00	Neutral ➝ Neutral
ULS UL Solutions	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephanie Yee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.05 -1.8%	$55.00 ➝ $58.00	Overweight ➝ Overweight
UPBD Upbound Group	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Chukumba Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.56 -3.9%	$33.00 ➝ $30.00	Hold ➝ Hold
V Visa	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Friedman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$348.27 -0.6%	$395.00 ➝ $410.00	Positive ➝ Positive
VAL Valaris	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Minervino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.80 -6.2%	$50.00 ➝ $47.00	Neutral ➝ Neutral
VERI Veritone	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.85 -3.1%		Buy
VERV Verve Therapeutics	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.28 -7.0%		Outperform
VICI VICI Properties	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Simon Yarmak Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.25 +1.6%	$33.75 ➝ $34.00	Buy ➝ Buy
VIST Vista Energy	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$54.27 -2.0%	$65.40	Buy
VRSK Verisk Analytics	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$295.11 +0.8%	$313.00 ➝ $325.00	Overweight ➝ Overweight
VTLE Vital Energy	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Neal Dingmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.77 -6.9%	$49.00 ➝ $47.00	Buy ➝ Buy
W Wayfair	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Maria Ripps Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$76.00 ➝ $68.00	Buy ➝ Buy
W Wayfair	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$52.00 ➝ $50.00	Neutral ➝ Neutral
W Wayfair	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Mcternan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$50.00 ➝ $50.00	Buy ➝ Buy
W Wayfair	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Kelley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$47.00 ➝ $46.00	Hold ➝ Hold
W Wayfair	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laura Champine Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$55.00 ➝ $45.00	Hold ➝ Hold
W Wayfair	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Youssef Squali Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$55.00 ➝ $53.00	Buy ➝ Buy
W Wayfair	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Pitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$50.00 ➝ $55.00	Market Perform ➝ Market Perform
W Wayfair	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$58.00	Overweight ➝ Overweight
W Wayfair	Target Set by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bobby Griffin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$60.00	Strong-Buy ➝ Strong-Buy
W Wayfair	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Basham Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -9.0%	$44.00 ➝ $46.00	Neutral
WEAV Weave Communications	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alexander Sklar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.26 -15.6%	$17.00 ➝ $20.00	Strong-Buy ➝ Strong-Buy
WING Wingstop	Downgraded by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Sanderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$234.02 -5.3%		Buy ➝ Neutral
WIX Wix.com	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Jeffries Subscribe to MarketBeat All Access for the recommendation accuracy rating	$198.11 -2.7%	$249.00 ➝ $262.00	Overweight ➝ Overweight
WKC World Kinect	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Benjamin Nolan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$30.72 +11.3%	$32.00 ➝ $30.00	Hold ➝ Hold
WMT Walmart	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.70 -2.6%	$115.00 ➝ $115.00	Outperform ➝ Outperform
WMT Walmart	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Vinh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.70 -2.6%	$100.00 ➝ $105.00	Overweight ➝ Overweight
WMT Walmart	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bill Kirk Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.70 -2.6%	$97.00 ➝ $108.00	Buy ➝ Buy
WMT Walmart	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.70 -2.6%	$109.00 ➝ $107.00	Outperform ➝ Outperform
WMT Walmart	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.70 -2.6%	$113.00 ➝ $112.00	Buy ➝ Buy
XYZ Block	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rayna Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.34 -17.7%	$98.00 ➝ $97.00	Buy ➝ Buy
XYZ Block	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.34 -17.7%	$109.00 ➝ $94.00	Buy ➝ Buy
XYZ Block	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.34 -17.7%	$120.00 ➝ $100.00	Buy ➝ Buy
XYZ Block	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Davis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.34 -17.7%	$115.00 ➝ $103.00	Outperform ➝ Outperform
XYZ Block	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.34 -17.7%	$90.00 ➝ $90.00	Buy ➝ Buy
XYZ Block	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vasundhara Govil Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.34 -17.7%	$100.00 ➝ $87.00	Market Perform ➝ Market Perform
YOU Clear Secure	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.58 +5.3%	$42.00 ➝ $42.00	Outperform ➝ Outperform
ZS Zscaler	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$198.56 -4.1%	$220.00 ➝ $250.00	Overweight ➝ Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:19 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Top Headlines and Offers

View All

Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
By Ryan Hasson | February 19, 2025
View Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
By Sarah Horvath | February 18, 2025
View DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
Warning: Elon’s $20k Robot Might Replace Your Nanny
From WealthPress(Ad)
View Warning: Elon’s $20k Robot Might Replace Your Nanny
3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
By Gabriel Osorio-Mazilli | February 21, 2025
View 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
Should You Hold NVIDIA Stock for the Long Haul or Trade It?
By Gabriel Osorio-Mazilli | February 20, 2025
View Should You Hold NVIDIA Stock for the Long Haul or Trade It?
Analysts See Buying Opportunity in NVIDIA Before Earnings
By Thomas Hughes | February 18, 2025
View Analysts See Buying Opportunity in NVIDIA Before Earnings
This Crypto Is Set to Explode in February
From Crypto 101 Media(Ad)
View This Crypto Is Set to Explode in February
Conflicting Signals: Tempus AI's Stock Market Rally
By Jeffrey Neal Johnson | February 17, 2025
View Conflicting Signals: Tempus AI's Stock Market Rally
Ray Dalio's Bridgewater Loaded Up on These Stocks in Q4 2024
By Leo Miller | February 20, 2025
View Ray Dalio's Bridgewater Loaded Up on These Stocks in Q4 2024
Hims & Hers Earnings Could Be a Game Changer—What to Do Now
By Gabriel Osorio-Mazilli | February 18, 2025
View Hims & Hers Earnings Could Be a Game Changer—What to Do Now
As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
By Chris Markoch | February 21, 2025
View As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Palantir Stock Skids—How Much Further Can It Fall?
By Chris Markoch | February 21, 2025
View Palantir Stock Skids—How Much Further Can It Fall?

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings